EUVIMEDEUVIMED entdecken
Kohortenstudie

Body Roundness Index and All‐Cause Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Dual‐Cohort Study

Zijian Li, Shishu Yin iD, Jian Cui, Jinxin Shi, Fuhai Ma, Tianming Ma, Qi An, Tao Yu, Danian Tang, Xianglong Cao, Gang Zhao

Diabetes, Obesity and Metabolism · 2026-06 · 28 (6) · 4961-4974

DOI: 10.1111/dom.70685 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 26.03.2026. Verfasst von Zijian Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences…. Hauptthemen laut MEDLINE: Body Mass Index, Fatty Liver, Non-alcoholic Fatty Liver Disease, Metabolic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Corps Key Areas of Scientific and Technological Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether associations between the body roundness index (BRI) and mortality differ across population settings in metabolic dysfunction‐associated steatotic liver disease (MASLD) remains unclear.

Methods

We analysed two nationally representative cohorts: NHANES (1999–2018; n = 7723; US population) and CHARLS (2011–2020; n = 6553; Chinese population). Cox proportional hazards regression with restricted cubic splines was used to assess dose–response relationships. Between‐cohort heterogeneity was evaluated using I 2 statistics.

Results

In NHANES (mean BMI, 31.99 kg/m 2 ; 924 deaths over median follow‐up of 8.9 years), BRI demonstrated a significant linear association with all‐cause mortality (hazard ratio [HR], 1.18 per SD; 95% confidence interval [CI], 1.049–1.327; p = 0.006). In CHARLS (mean BMI, 25.73 kg/m 2 ; 110 deaths over median follow‐up of 7.3 years), no significant association was observed (HR, 0.91; 95% CI, 0.749–1.101; p = 0.327). Between‐cohort heterogeneity was substantial ( I 2 = 80.7%; p = 0.023). In NHANES, the triglyceride‐glucose (TyG) index was associated with 33.8% (95% CI, 18.2%–52.4%) statistical attenuation of the BRI‐mortality association. The null finding in CHARLS likely reflects insufficient power (14% to detect HR = 1.18) rather than evidence against an association, highlighting the need for adequately powered studies.

Conclusions

BRI demonstrates a significant linear association with mortality in the US MASLD population. In the Chinese elderly MASLD population, statistical power was insufficient to draw definitive conclusions about BRI‐mortality associations. The observed between‐cohort heterogeneity likely reflects multiple factors, including differences in age structure, obesity phenotype, mortality ascertainment methods, and potentially genuine population‐specific characteristics. These findings underscore the importance of population‐specific validation before extrapolating Western‐derived BRI thresholds to Asian populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body Mass IndexFatty LiverNon-alcoholic Fatty Liver DiseaseMetabolic DiseasesHumansMaleFemaleCohort StudiesMiddle AgedNutrition SurveysUnited StatesAgedAdultProportional Hazards ModelsRisk Factors

Stichwörter der Autor:innen

all‐cause mortalitybody roundness indexchronic inflammationmetabolic dysfunction‐associated steatotic liver diseasepopulation heterogeneity

Autor:innen und Institutionen

  • Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

ORCID-Profile: Shishu Yin

Förderung

  • Corps Key Areas of Scientific and Technological Research

Zitieren

APA

Li, Z., Yin, S., Cui, J., Shi, J., Ma, F., Ma, T., An, Q., Yu, T., Tang, D., Cao, X., & Zhao, G. (2026). Body Roundness Index and All‐Cause Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Dual‐Cohort Study. Diabetes, Obesity and Metabolism, 28(6), 4961-4974. https://doi.org/10.1111/dom.70685

Vancouver

Li Z, Yin S, Cui J, Shi J, Ma F, Ma T, et al. Body Roundness Index and All‐Cause Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Dual‐Cohort Study. Diabetes, Obesity and Metabolism. 2026;28(6):4961-4974. doi:10.1111/dom.70685

BibTeX
@article{Li2026,
  author = {Li, Zijian and Yin, Shishu and Cui, Jian and Shi, Jinxin and Ma, Fuhai and Ma, Tianming and An, Qi and Yu, Tao and Tang, Danian and Cao, Xianglong and Zhao, Gang},
  title = {Body Roundness Index and All‐Cause Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Dual‐Cohort Study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {4961--4974},
  doi = {10.1111/dom.70685}
}
Kostenlos starten →